18F-AV-1451 PET imaging in pre-dementia Parkinson’s disease
Objective: To describe cortical and subcortical 18F-AV-1451 binding in Parkinson’s disease patients with and without mild cognitive impairment (PD-MCI and PD-nonMCI). Background: The radioligand 18F-AV-1451…Marked occipital hypometabolism on FDG-PET in patients with idiopathic RBD may predict Parkinson’s disease
Objective: In the present study, we tried to elucidate if the occipital hypometabolism detected by [(18) F]-fluoro-d-glucose (FDG) positron emission tomography (PET) scan in patients with idiopathic…The Putamen to Caudate Nucleus Ratio: A Simple Surrogate Marker for Dopaminergic Volume in Putamen
Objective: To investigate the simple parameter by which fully represent the level of nigral dopamine in putamen by means of routine 18F-FP-CIT positron emission tomography…Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG PET imaging
Objective: To characterize the clinical features and the neuroanatomical bases of cognitive impairment in Parkinson’s disease (PD) with respect to attention, executive function, memory, language,…Gait asymmetry in people with Parkinson’s disease is linked to reduced integrity of callosal sensorimotor regions
Objective: To evaluate the relationship between gait asymmetry and the integrity of the corpus callosum connecting sensorimotor cortical regions in people with idiopathic Parkinson’s Disease…Medically refractory paroxysmal kinesigenic dyskinesia in a 7 year old with a novel PRRT2 mutation
Objective: To describe an atypical case of paroxysmal kinesigenic dyskinesia (PKD) due to a novel PRRT2 mutation. Background: PRRT2 gene mutations have been reported in a…Spanish Primary Familial Brain Calcification caused by SLC20A2 mutation
Objective: To describe clinical and radiological features of a Spanish family with Primary Familial Brain Calcification (PFBC) and genetic results of the index case. Background:…The SYNAPSES study (StudY to observe SafiNAmide in clinical Practice during the firSt post-commErcialization phaSe): methodology and results from the European feasibility survey
Objective: Here we present the design of a Drug Utilization Study of safinamide in the first post-commercialization phase and report results of the study feasibility…Serum cholesterol levels over time and risk of Parkinson’s disease
Objective: To evaluate the association of serum cholesterol levels over time with the risk of Parkinson's disease (PD); among statin-free individuals. Background: High levels of…Investigation of Non-Motor Symptoms Impacting Care Dependency in Individuals with Parkinson’s Disease
Objective: To examine what extent non-motor symptoms of Parkinson’s disease (PD) predict care dependence in individuals with PD. Background: The main aim of medical management…
- « Previous Page
- 1
- …
- 76
- 77
- 78
- 79
- 80
- …
- 155
- Next Page »